[Now open] GHIT Fund’s new Request for Proposals

The Global Health Innovative Technology Fund (GHIT Fund) invests in the research and development of new health technologies, including drugs, vaccines and diagnostics for infectious diseases prevalent in low-income countries (LICs) and lower-middle-income countries (LMICs), such as malaria, tuberculosis, and neglected tropical diseases (NTDs).

We are pleased to announce the GHIT Fund Request for Proposal (RFP) for the Product Development Platform (PD), the Target Research Platform (TRP), and the Hit-to-Lead Platform (HTLP). The GHIT Fund issues RFPs twice a year. For more details on the RFPs, please refer to the following links.
■    Product Development Platform (PD)
■    Target Research Platform (TRP)
■    Hit-to-Lead Platform (HTLP)

An overview of the funding opportunities can be found here:
https://www.ghitfund.org/applyforfunding/opportunities/en

For frequently asked questions on the GHIT Fund investments, please also refer to Investment FAQs:
https://www.ghitfund.org/applyforfunding/investmentfaq/en